Deerfield Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,821
| Closed | -$281K | – | 484 |
|
|
2024
Q1 | $281K | Buy |
+8,821
| New | +$281K | ﹤0.01% | 271 |
|
|
2023
Q4 | – | Sell |
-650,000
| Closed | -$8.27M | – | 227 |
|
|
2023
Q3 | $8.27M | Hold |
650,000
| – | – | 0.18% | 62 |
|
|
2023
Q2 | $11.7M | Buy |
+650,000
| New | +$11.7M | 0.25% | 66 |
|
|
2021
Q2 | – | Sell |
-150,000
| Closed | -$6.51M | – | 150 |
|
|
2021
Q1 | $6.51M | Hold |
150,000
| – | – | 0.14% | 114 |
|
|
2020
Q4 | $6.22M | Buy |
+150,000
| New | +$6.22M | 0.12% | 116 |
|